Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jul 30, 2010

Premium

Gentel Biosciences started sales this week of its APiX Disease Profiling Kit, a single-capture antibody array and detection kit that the company said can be used for profiling hundreds of disease-related proteins across multiple disease states.

The kit works with the Gentel Proteomics Multi-System and AthenaQuant software suite and can be used for studying tumor-associated antigens, comparing proteomic and transcriptomic data, and performing target identification and validation, the company said.


GE Healthcare launched this week its Biacore T200 system for the measurement of kinetic, affinity, concentration, specificity, and thermodynamic interaction data for the characterization of biomolecular interactions.

The system allows for guided workflows and the analysis of up to 384 samples in unattended runs. It also offers calibration-free concentration analysis that enables measurement of active protein concentrations whether or not a standard is available, the company said.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.